This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokushima, JP (2010 - 2013)
- Osaka, JP (2015)
Company Filing History:
Years Active: 2010-2015
Title: Hironobu Ishiyama: Innovator in Stem Cell Research
Introduction
Hironobu Ishiyama is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of stem cell research, holding a total of 5 patents. His work focuses on therapeutic applications derived from human monocytes, showcasing his commitment to advancing medical science.
Latest Patents
Ishiyama's latest patents include groundbreaking inventions such as a stem cell for therapeutic use derived from human monocytes. This invention involves culturing monocytes in the presence of M-CSF and specific plant-derived extracts to dedifferentiate them. Additionally, he has developed a therapeutic agent aimed at treating damaged cells, tissues, or organs, along with a method for producing stem cells and a culture medium for dedifferentiating monocytes. Another notable patent involves thiazole compounds that inhibit phosphodiesterase 4, tumor necrosis factor alpha, and interleukin 4, demonstrating his innovative approach to addressing complex medical challenges.
Career Highlights
Ishiyama is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to push the boundaries of research and development. His work has not only contributed to the scientific community but has also paved the way for potential therapeutic advancements in regenerative medicine.
Collaborations
Throughout his career, Ishiyama has collaborated with esteemed colleagues such as Takumi Sumida and Kunio Oshima. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.
Conclusion
Hironobu Ishiyama's contributions to stem cell research and his innovative patents reflect his dedication to improving healthcare solutions. His work continues to inspire future advancements in the field of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile